Delivery Order SPE2DB22D3301-SPE2DB23FZ3AF
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $25,931.08 to Amerisourcebergen Drug Corporation for 4561919850 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,640.84 to Amerisourcebergen Drug Corporation for 4561772767 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,258.76 to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication. This non-competitive, firm fixed-price delivery order was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,412.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 mg vials of ABRAXANE, a chemotherapy medication used to treat breast and lung cancers. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and various Department of Defense medical treatment facilities. Amerisourcebergen will fulfill the order from its facility located in Conshohocken,...
- The Defense Logistics Agency awarded a $8,480.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 100 mg vials of ABRAXANE, a chemotherapy drug. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and various Department of Defense medical treatment facilities. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required between...
- The Defense Logistics Agency Troop Support Medical awarded a $6,621.53 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of ABRAXANE. As the prime contractor, Amerisourcebergen Drug Corp will deliver the oncology drug to its place of performance in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The delivery order was placed against an existing DLA medical supply vehicle and does not have any set aside designations....
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. This firm fixed-price delivery order, valued at $8,436.70 with an ultimate completion date of June 25, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with a ceiling value of $3,781.37. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. This firm fixed-price delivery order, valued at $13,172.47, is scheduled for completion by April 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...